Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) has been named to TIME Canada's Best Companies 2026 list, marking the first time a cannabis company has received this recognition. The list, compiled by TIME in collaboration with Statista, evaluates Canadian companies with at least US$100 million in revenue and positive revenue growth over three years, considering employee satisfaction, revenue growth, and sustainability transparency. Only 125 companies earned a place on the final list.
Aurora's Historic Achievement
This award reflects Aurora's differentiated performance and commitment to industry excellence. The company's inclusion underscores its people-first culture and continued investment in creating a supportive workplace. Through leadership development programs, wellness initiatives, and community giving, Aurora has built a culture grounded in its values and purpose of Opening the World to Cannabis.
“This is a proud milestone for Aurora and a meaningful recognition of our leadership strength in Canada,” said Miguel Martin, CEO & Executive Chairman of Aurora. “Above all, this recognition belongs to our people. Every day, our teams bring deep expertise, care and commitment to advancing medical cannabis globally, and being named to TIME’s Canada’s Best Companies 2026 list is a powerful signal of the progress we’ve made, the credibility we’ve earned, and the standard we continue to set.”
Evaluation Methodology
The ranking process involved a multi-step evaluation of Canadian companies with at least US$100 million in revenue in 2024 or 2025 and positive revenue growth over three years. Both relative and absolute growth were assessed. Employee satisfaction was measured through surveys, and sustainability transparency was evaluated based on environmental, social, and governance (ESG) disclosures. Aurora's strong performance across these criteria earned it a spot among Canada's best employers.
About Aurora Cannabis
Aurora is a global leader in medical cannabis, serving markets across Canada, Europe, Australia, and New Zealand. Its portfolio includes trusted brands such as Aurora, MedReleaf, Pedanios, IndiMed, San Raf, and Whistler Medical Marijuana Corporation. The company operates world-class GMP-certified manufacturing facilities in Canada and Germany and continues to expand its global footprint. Aurora's common shares trade on the NASDAQ and TSX under the symbol ACB.
Forward-Looking Statements
This news release contains forward-looking statements regarding the company's ongoing commitment to investing in its people and accelerating the advancement of the global medical cannabis industry. These statements are subject to risks and uncertainties that could cause actual results to differ materially.
